Coverage
-
April 24, 2023
A woman accusing a cosmetics company of selling eyelash-growth serums with an ingredient purportedly associated with severe adverse impacts says she's reached a $6.25 million class settlement to resolve the dispute.
1 other articles on this case.
View all »